15.361 articles found

Expanding the clinical spectrum of STIP1 homology and U-box containing protein 1-associated ataxia.

Ravel JM, Benkirane M, Calmels N, Marelli C, Ory-Magne F, Ewenczyk C, Halleb Y, Tison F, Lecocq C, Pische G, Casenave P, Chaussenot A, Frismand S, Tyvaert L, Larrieu L, Pointaux M, Drouot N, Bossenmeyer-Pourié C, Oussalah A, Guéant JL, Leheup B, Bonnet C, Anheim M, Tranchant C, Lambert L, Chelly J, Koenig M, Renaud M.

J Neurol · 2021-01-08

DOI: 10.1007/s00415-020-10348-xPMID: 33417001

Personality dimensions of patients can change during the course of parkinson's disease.

Boussac M, Arbus C, Dupouy J, Harroch E, Rousseau V, Croiset A, Ory-Magne F, Rascol O, Moreau C, Rolland AS, Maltête D, Rouaud T, Meyer M, Drapier S, Giordana B, Anheim M, Hainque E, Jarraya B, Benatru I, Auzou N, Belamri L, Tir M, Marques AR, Thobois S, Eusebio A, Corvol JC, Devos D, Brefel-Courbon C, PREDI-STIM study group.

PLoS One · 2021-01-07

DOI: 10.1371/journal.pone.0245142PMID: 33411732

New Approaches Based on Non-Invasive Brain Stimulation and Mental Representation Techniques Targeting Pain in Parkinson's Disease Patients: Two Study Protocols for Two Randomized Controlled Trials.

González-Zamorano Y, Fernández-Carnero J, Sánchez-Cuesta FJ, Arroyo-Ferrer A, Vourvopoulos A, Figueiredo P, Serrano JI, Romero JP.

Brain Sci · 2021-01-06

DOI: 10.3390/brainsci11010065PMID: 33561080

Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease.

Suzuki K, Fujita H, Matsubara T, Haruyama Y, Kadowaki T, Funakoshi K, Watanabe Y, Hirata K.

Brain Behav · 2021-01-05

DOI: 10.1002/brb3.2026PMID: 33399276

Pimavanserin Treatment for Parkinson's Disease Psychosis in Clinical Practice.

Dashtipour K, Gupta F, Hauser RA, Karunapuzha CA, Morgan JC.

Parkinsons Dis · 2021-01-04

DOI: 10.1155/2021/2603641PMID: 33489083

High intensity aerobic exercise improves information processing and motor performance in individuals with Parkinson's disease.

Rosenfeldt AB, Koop MM, Fernandez HH, Alberts JL.

Exp Brain Res · 2021-01-04

DOI: 10.1007/s00221-020-06009-0PMID: 33394100

Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study).

Cho SY, Jeong SJ, Lee S, Kim J, Lee SH, Choo MS, Oh SJ.

Neurourol Urodyn · 2021-01-03

DOI: 10.1002/nau.24552PMID: 33389776

Increased atrial fibrillation risk in Parkinson's disease: A nationwide population-based study.

Han S, Moon I, Choi EK, Han KD, Cho HC, Lee SY, Yang S, Kwon S, Choi YJ, Lee HJ, Lee E, Lee SR, Oh S.

Ann Clin Transl Neurol · 2021-01-03

DOI: 10.1002/acn3.51279PMID: 33389803

Dual Tasking Influences Cough Reflex Outcomes in Adults with Parkinson's Disease: A Controlled Study.

Perry SE, Troche MS.

Dysphagia · 2021-01-02

DOI: 10.1007/s00455-020-10223-xPMID: 33387000

The clinical spectrum, pathological and proteomic features of dementia with Lewy bodies and Parkinson's disease dementia

Hansen D.

· 2021-01-01

Delayed Clinical Manifestation of Parkinson's Disease Among Physically Active: Do Participants in a Long-Distance Ski Race Have a Motor Reserve?

Olsson TT, Svensson M, Hållmarker U, James S, Deierborg T.

J Parkinsons Dis · 2021-01-01

DOI: 10.3233/jpd-200004PMID: 32623406

Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches.

Duarte P, Cuadrado A, León R.

Handb Exp Pharmacol · 2021-01-01

DOI: 10.1007/164_2020_384PMID: 32852645